Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics, Q4 2011

Feb 27 2012

• By Deanna Kamienski

Related Content

Third Rock Wise To The Opportunity In CNS; Stakes SAGE Therapeutics With $35 Million

Oct 18 2011

Clovis Oncology Seeks $149.5 Million IPO

Jun 23 2011

Salix Expects Acquisition Of Oceana, Two Products, To Be Quickly Accretive

Nov 09 2011

Bard Buys Lutonix For Lead In Race To U.S. Market With Drug-Coated Balloon

Jan 02 2012

Foundation Medicine Seeks "Go-To" Companion Diagnostic Status For Sequencing Test

Jun 20 2011

Related Companies

Biocartis NV

Clovis Oncology, Inc.

Bristol Myers Squibb Company

AqualisBraemar ASA

Roche Holding AG

Ventana Medical Systems, Inc.

Verastem, Inc.

Massachusetts Institute of Technology

Massachusetts Institute of Technology

Agios Pharmaceuticals, Inc.

Puma Biotechnology, Inc.

Pfizer Inc.

Dermira Inc.

Cleave Therapeutics, Inc.

Aptalis Pharma Inc.

Stryker Corporation

Arsenal Medical, Inc.

480 Biomedical, Inc.

Pacific Biosciences of California, Inc.

Johnson & Johnson

Johnson & Johnson

BeOne Medicines Ltd.

Foundation Medicine, Inc.

Johnson & Johnson

Johnson & Johnson

Metamark Genetics Inc.

Johnson & Johnson

TopiVert Pharma Limited

Ligand Pharmaceuticals, Inc.

Chiva Pharmaceuticals, Inc.

Sage Therapeutics, Inc.

Samsung Bioepis Co., Ltd.

Samsung Bioepis Co., Ltd.

Biogen, Inc.

IQVIA Holdings Inc.

Sorin Group

Rainbow Medical Ltd.

Aptargroup, Inc.

SMC Ltd.

ADx NeuroSciences NV

OvaGene Oncology Inc.

University of South Florida

Moffitt Cancer Center

Additional Topics

Deals BioPharmaceutical Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window